EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $674,010 | -39.2% | 42,740 | -25.0% | 0.00% | – |
| Q2 2023 | $1,108,197 | -46.8% | 57,006 | -22.3% | 0.00% | – |
| Q1 2023 | $2,082,358 | +275.9% | 73,400 | +287.3% | 0.00% | – |
| Q4 2022 | $553,938 | +11.0% | 18,951 | +0.2% | 0.00% | – |
| Q3 2022 | $499,000 | +6.6% | 18,904 | +100.0% | 0.00% | – |
| Q1 2022 | $468,000 | -79.4% | 9,451 | -78.8% | 0.00% | – |
| Q4 2021 | $2,268,000 | +21.9% | 44,532 | +33.5% | 0.00% | – |
| Q3 2021 | $1,861,000 | +365.2% | 33,369 | +256.7% | 0.00% | – |
| Q2 2021 | $400,000 | +60.6% | 9,355 | +57.0% | 0.00% | – |
| Q1 2021 | $249,000 | -75.0% | 5,957 | -74.6% | 0.00% | – |
| Q3 2020 | $997,000 | +4.9% | 23,472 | +18.5% | 0.00% | – |
| Q2 2020 | $950,000 | -52.5% | 19,800 | -54.4% | 0.00% | – |
| Q1 2020 | $1,998,000 | -67.1% | 43,445 | -57.1% | 0.00% | -100.0% |
| Q4 2019 | $6,080,000 | +307.0% | 101,200 | +283.1% | 0.00% | – |
| Q3 2019 | $1,494,000 | -94.4% | 26,417 | -94.5% | 0.00% | -100.0% |
| Q2 2019 | $26,909,000 | +370.4% | 483,296 | +326.7% | 0.00% | +50.0% |
| Q1 2019 | $5,720,000 | +12.0% | 113,273 | -10.6% | 0.00% | 0.0% |
| Q4 2018 | $5,106,000 | -70.1% | 126,747 | -48.5% | 0.00% | -66.7% |
| Q3 2018 | $17,049,000 | +5.1% | 245,900 | +14.6% | 0.01% | 0.0% |
| Q2 2018 | $16,229,000 | +114.9% | 214,500 | +49.6% | 0.01% | +200.0% |
| Q1 2018 | $7,553,000 | +12.6% | 143,335 | +14.1% | 0.00% | 0.0% |
| Q4 2017 | $6,708,000 | +25.5% | 125,578 | +40.2% | 0.00% | 0.0% |
| Q3 2017 | $5,344,000 | -44.7% | 89,600 | -26.9% | 0.00% | -50.0% |
| Q2 2017 | $9,672,000 | -2.2% | 122,600 | +2.9% | 0.00% | -20.0% |
| Q1 2017 | $9,886,000 | -59.2% | 119,200 | -61.0% | 0.01% | -61.5% |
| Q4 2016 | $24,254,000 | +41.2% | 305,700 | +24.6% | 0.01% | +44.4% |
| Q3 2016 | $17,171,000 | +216.4% | 245,300 | +75.3% | 0.01% | +200.0% |
| Q2 2016 | $5,427,000 | -36.3% | 139,900 | -33.5% | 0.00% | -40.0% |
| Q1 2016 | $8,521,000 | -7.2% | 210,400 | +103.2% | 0.01% | +25.0% |
| Q4 2015 | $9,182,000 | -24.3% | 103,553 | -36.8% | 0.00% | -33.3% |
| Q3 2015 | $12,133,000 | +102.8% | 163,898 | +121.5% | 0.01% | +200.0% |
| Q2 2015 | $5,982,000 | +380.1% | 73,978 | +148.7% | 0.00% | +100.0% |
| Q1 2015 | $1,246,000 | – | 29,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |